Adeslas PET-CT authorisation: documentation, amount and billing risk
For high-value tests such as PET-CT with Adeslas, the clinic should confirm authorisation, prescription, report, code or test description, date and identifier before billing. Adeslas publishes a general 30-calendar-day rule for authorisations; concrete PET-CT applicability depends on policy and agreement (TO_VERIFY).
Why PET-CT weighs more in the queue
An administrative error in PET-CT weighs more than in a smaller act. Amount, clinical documentation and authorisation date must line up before billing.
Calculate revenue lost to authorisations
Use the SaludComply authorisation diagnostic to estimate monthly loss, recoverable range and operational complexity. No patient data required.
What the clinic should check
The clinic should check prescription, report, PET-CT code or description, scheduled date, authorisation, identifier and invoice. If the appointment moves, it should also review whether the identifier remains valid.
How SaludComply approaches it
SaludComply surfaces high-value cases with realistic recovery, explains missing evidence and prepares the next action for admin review. Nothing is sent without clinic approval.
Frequently asked questions
- Does PET-CT with Adeslas require authorisation?
- It should be confirmed by policy, test and centre agreement. Adeslas publishes general authorisation and 30-calendar-day validity information, but the clinic should validate the concrete case.
Verified sources
- Adeslas — Autorizaciones — fuente oficial sobre proceso y caducidad
- SaludComply — diagnóstico de autorizaciones — diagnóstico de fuga por autorizaciones